Ушбу иш иқтибос қилган ишлар

154 та иш

Иш: A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance

Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications
Nida Iqbal, Nida Iqbal, Naveed Iqbal +1
Шарҳ мақола20146 иқтибос
ABI
Comprehensive review of targeted therapy for colorectal cancer
Yuanhong Xie, Yingxuan Chen, Jing‐Yuan Fang
Шарҳ мақола20205 иқтибос
ABI
Diagnosis and Treatment of Metastatic Colorectal Cancer
Leah H. Biller, Deborah Schrag
Шарҳ мақола20214 иқтибос
ABI
The Role of mTOR Signaling as a Therapeutic Target in Cancer
N. V. Popova, Manfred Jücker
Шарҳ мақола20213 иқтибос
ABI
AKT/PKB Signaling: Navigating the Network
Brendan D. Manning, Alex Toker
Шарҳ мақола20173 иқтибос
ABI
Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies
Nannan Wang, Yuepeng Cao, Chengshuai Si +5
Шарҳ мақола20223 иқтибос
ABI
Immune Checkpoint Inhibitors in Cancer Therapy
Yavar Shiravand, Faezeh Khodadadi, Seyyed Mohammad Amin Kashani +6
Шарҳ мақола20223 иқтибос
ABI
Characteristics of the cancer stem cell niche and therapeutic strategies
Feng Ju, Manar Atyah, Nellie Horstmann +6
Шарҳ мақола20223 иқтибос
ABI
Small Molecule EGFR Inhibitors as Anti-Cancer Agents: Discovery, Mechanisms of Action, and Opportunities
Tanzida Zubair, Debasish Bandyopadhyay
Шарҳ мақола20233 иқтибос
ABI
Autophagy, cancer stem cells and drug resistance
Alexandra G. Smith, Kay F. Macleod
Шарҳ мақола20182 иқтибос
ABI
VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
Yueshui Zhao, Sipeng Guo, Jian Min Deng +13
Шарҳ мақола20222 иқтибос
ABI
The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer
Jennifer L. Hsu, Mien‐Chie Hung
Шарҳ мақола20162 иқтибос
ABI
The ErbB/HER family of protein-tyrosine kinases and cancer
Robert Roskoski
Шарҳ мақола20132 иқтибос
ABI
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?
Giuseppe Bronte, Nicola Silvestris, Marta Castiglia +10
Шарҳ мақола20152 иқтибос
ABI
Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Gang Niu, Xiaoyuan Chen
Шарҳ мақола20102 иқтибос
ABI
Microsatellite Instability in Colorectal Cancer
C. Richard Boland, Ajay Goel
Шарҳ мақола20102 иқтибос
ABI
Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years
Mariusz Pańczyk
Шарҳ мақола20142 иқтибос
ABI
The emerging clinical relevance of genomics in cancer medicine
Michael F. Berger, Elaine R. Mardis
Шарҳ мақола20182 иқтибос
ABI
NTRK fusion-positive cancers and TRK inhibitor therapy
Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon
Шарҳ мақола20182 иқтибос
ABI
Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?
Olivier Gires, Min Pan, Henrik Schinke +2
Шарҳ мақола20202 иқтибос
ABI
Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
Constantin Ștefani, Daniela Miricescu, Iulia-Ioana Stănescu-Spînu +4
Шарҳ мақола20212 иқтибос
ABI
Impact of<scp>DNA</scp>damage response defects in cancer cells on response to immunotherapy and radiotherapy
Daniel Czajkowski, Radosław Szmyd, Harriet E. Gee
Шарҳ мақола20222 иқтибос
ABI
HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target
Selma Ahcene Djaballah, Francesca Daniel, A. Milani +2
Мақола20222 иқтибос
ABI
DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities
Dana Jurkovičová, Christiana M. Neophytou, Ana Čipak Gašparović +1
Шарҳ мақола20222 иқтибос
ABI
Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments
Yuanling Tang, Dandan Li, Jiayu Duan +2
Шарҳ мақола20232 иқтибос
ABI